228 related articles for article (PubMed ID: 30247463)
1. Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening.
Griner LM; Gampa K; Do T; Nguyen H; Farley D; Hogan CJ; Auld DS; Silver SJ
J Vis Exp; 2018 Sep; (139):. PubMed ID: 30247463
[TBL] [Abstract][Full Text] [Related]
2. Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems.
Patel NR; Aryasomayajula B; Abouzeid AH; Torchilin VP
Ther Deliv; 2015; 6(4):509-20. PubMed ID: 25996047
[TBL] [Abstract][Full Text] [Related]
3. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array.
Tung YC; Hsiao AY; Allen SG; Torisawa YS; Ho M; Takayama S
Analyst; 2011 Feb; 136(3):473-8. PubMed ID: 20967331
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric Analysis of Oncology Drug Screening with Aqueous Two-Phase Tumor Spheroids.
Shahi Thakuri P; Ham SL; Luker GD; Tavana H
Mol Pharm; 2016 Nov; 13(11):3724-3735. PubMed ID: 27653969
[TBL] [Abstract][Full Text] [Related]
5. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
6. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
[TBL] [Abstract][Full Text] [Related]
7. A simple, reliable method for high-throughput screening for diabetes drugs using 3D β-cell spheroids.
Amin J; Ramachandran K; Williams SJ; Lee A; Novikova L; Stehno-Bittel L
J Pharmacol Toxicol Methods; 2016; 82():83-89. PubMed ID: 27554916
[TBL] [Abstract][Full Text] [Related]
8. Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening.
Guo WM; Loh XJ; Tan EY; Loo JS; Ho VH
Mol Pharm; 2014 Jul; 11(7):2182-9. PubMed ID: 24842574
[TBL] [Abstract][Full Text] [Related]
9. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.
Howes AL; Richardson RD; Finlay D; Vuori K
PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711
[TBL] [Abstract][Full Text] [Related]
10. Three-Dimensional Aggregated Spheroid Model of Hepatocellular Carcinoma Using a 96-Pillar/Well Plate.
Lee SY; Teng Y; Son M; Ku B; Hwang HJ; Tergaonkar V; Chow PK; Lee DW; Nam DH
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443536
[TBL] [Abstract][Full Text] [Related]
11. Thermo-responsive polymer aided spheroid culture in cryogel based platform for high throughput drug screening.
Sarkar J; Kumar A
Analyst; 2016 Apr; 141(8):2553-67. PubMed ID: 27027476
[TBL] [Abstract][Full Text] [Related]
12. Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug Efficacy.
Wilson KM; Mathews-Griner LA; Williamson T; Guha R; Chen L; Shinn P; McKnight C; Michael S; Klumpp-Thomas C; Binder ZA; Ferrer M; Gallia GL; Thomas CJ; Riggins GJ
SLAS Technol; 2019 Feb; 24(1):28-40. PubMed ID: 30289729
[TBL] [Abstract][Full Text] [Related]
13. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart LA; Freyer JP; Hofstaedter F; Ebner R
J Biomol Screen; 2004 Jun; 9(4):273-85. PubMed ID: 15191644
[TBL] [Abstract][Full Text] [Related]
14. Single and Combination Drug Screening with Aqueous Biphasic Tumor Spheroids.
Shahi Thakuri P; Tavana H
SLAS Discov; 2017 Jun; 22(5):507-515. PubMed ID: 28324660
[TBL] [Abstract][Full Text] [Related]
15. An image-based assay to quantify changes in proliferation and viability upon drug treatment in 3D microenvironments.
Murali VS; Chang BJ; Fiolka R; Danuser G; Cobanoglu MC; Welf ES
BMC Cancer; 2019 May; 19(1):502. PubMed ID: 31138163
[TBL] [Abstract][Full Text] [Related]
16. High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment.
Calpe B; Kovacs WJ
Expert Opin Drug Discov; 2020 Aug; 15(8):955-967. PubMed ID: 32364413
[TBL] [Abstract][Full Text] [Related]
17. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.
Sirenko O; Mitlo T; Hesley J; Luke S; Owens W; Cromwell EF
Assay Drug Dev Technol; 2015 Sep; 13(7):402-14. PubMed ID: 26317884
[TBL] [Abstract][Full Text] [Related]
18. High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.
Kochanek SJ; Close DA; Johnston PA
Assay Drug Dev Technol; 2019 Jan; 17(1):17-36. PubMed ID: 30592624
[TBL] [Abstract][Full Text] [Related]
19. ReN VM spheroids in matrix: A neural progenitor three-dimensional in vitro model reveals DYRK1A inhibitors as potential regulators of radio-sensitivity.
Wan X; Wu X; Hill MA; Ebner DV
Biochem Biophys Res Commun; 2020 Oct; 531(4):535-542. PubMed ID: 32807492
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput 3D Tumor Spheroid Screening Method for Cancer Drug Discovery Using Celigo Image Cytometry.
Kessel S; Cribbes S; Déry O; Kuksin D; Sincoff E; Qiu J; Chan LL
SLAS Technol; 2017 Aug; 22(4):454-465. PubMed ID: 27272155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]